JP2015529447A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529447A5
JP2015529447A5 JP2015518459A JP2015518459A JP2015529447A5 JP 2015529447 A5 JP2015529447 A5 JP 2015529447A5 JP 2015518459 A JP2015518459 A JP 2015518459A JP 2015518459 A JP2015518459 A JP 2015518459A JP 2015529447 A5 JP2015529447 A5 JP 2015529447A5
Authority
JP
Japan
Prior art keywords
filtration
use according
mbar
cell culture
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015518459A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529447A (ja
JP6220392B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/045663 external-priority patent/WO2013192009A1/en
Publication of JP2015529447A publication Critical patent/JP2015529447A/ja
Publication of JP2015529447A5 publication Critical patent/JP2015529447A5/ja
Application granted granted Critical
Publication of JP6220392B2 publication Critical patent/JP6220392B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015518459A 2012-06-21 2013-06-13 細胞培養培地のウイルスろ過 Active JP6220392B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261662814P 2012-06-21 2012-06-21
US61/662,814 2012-06-21
PCT/US2013/045663 WO2013192009A1 (en) 2012-06-21 2013-06-13 Virus filtration of cell culture media

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017137031A Division JP6557706B2 (ja) 2012-06-21 2017-07-13 細胞培養培地のウイルスろ過

Publications (3)

Publication Number Publication Date
JP2015529447A JP2015529447A (ja) 2015-10-08
JP2015529447A5 true JP2015529447A5 (cg-RX-API-DMAC7.html) 2016-09-15
JP6220392B2 JP6220392B2 (ja) 2017-10-25

Family

ID=48672845

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015518459A Active JP6220392B2 (ja) 2012-06-21 2013-06-13 細胞培養培地のウイルスろ過
JP2017137031A Expired - Fee Related JP6557706B2 (ja) 2012-06-21 2017-07-13 細胞培養培地のウイルスろ過
JP2018213613A Withdrawn JP2019022526A (ja) 2012-06-21 2018-11-14 細胞培養培地のウイルスろ過

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017137031A Expired - Fee Related JP6557706B2 (ja) 2012-06-21 2017-07-13 細胞培養培地のウイルスろ過
JP2018213613A Withdrawn JP2019022526A (ja) 2012-06-21 2018-11-14 細胞培養培地のウイルスろ過

Country Status (27)

Country Link
US (3) US9670456B2 (cg-RX-API-DMAC7.html)
EP (2) EP2732020B1 (cg-RX-API-DMAC7.html)
JP (3) JP6220392B2 (cg-RX-API-DMAC7.html)
KR (2) KR102008048B1 (cg-RX-API-DMAC7.html)
CN (2) CN104640969A (cg-RX-API-DMAC7.html)
AR (1) AR092847A1 (cg-RX-API-DMAC7.html)
AU (2) AU2013277532B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014031842B1 (cg-RX-API-DMAC7.html)
CA (1) CA2876473C (cg-RX-API-DMAC7.html)
CO (1) CO7151484A2 (cg-RX-API-DMAC7.html)
DK (2) DK3103861T3 (cg-RX-API-DMAC7.html)
EA (2) EA033006B1 (cg-RX-API-DMAC7.html)
ES (2) ES2601429T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20161435T1 (cg-RX-API-DMAC7.html)
HU (1) HUE031601T2 (cg-RX-API-DMAC7.html)
IL (2) IL236073B (cg-RX-API-DMAC7.html)
IN (1) IN2014DN10441A (cg-RX-API-DMAC7.html)
MX (2) MX386767B (cg-RX-API-DMAC7.html)
MY (2) MY195362A (cg-RX-API-DMAC7.html)
NZ (1) NZ629083A (cg-RX-API-DMAC7.html)
PL (2) PL2732020T3 (cg-RX-API-DMAC7.html)
PT (2) PT3103861T (cg-RX-API-DMAC7.html)
SG (2) SG11201408490PA (cg-RX-API-DMAC7.html)
SI (1) SI2732020T1 (cg-RX-API-DMAC7.html)
TW (2) TWI698522B (cg-RX-API-DMAC7.html)
WO (1) WO2013192009A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201409253B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014031842B1 (pt) * 2012-06-21 2020-09-15 Baxalta GmbH Método para remover um contaminante viral de uma preparação
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
SG10201507931QA (en) * 2014-12-22 2016-07-28 Emd Millipore Corp Removal of microorganisms from cell culture media
US20180072769A1 (en) * 2015-03-23 2018-03-15 Alexion Pharmaceuticals, Inc. Virus filtration
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
TWI870789B (zh) 2015-08-04 2025-01-21 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
US12157877B2 (en) * 2016-04-15 2024-12-03 Boehringer Ingelheim International Gmbh Cell retention device and method
US11034721B2 (en) * 2016-12-09 2021-06-15 Lonza Ltd Method for the reduction of viral titer in pharmaceuticals
MX2020000228A (es) * 2017-07-06 2020-08-10 Regeneron Pharma Proceso de cultivo celular para producir una glicoproteina.
TWI846694B (zh) * 2018-05-04 2024-07-01 美商健臻公司 具有過濾系統的灌注式生物反應器
CN113784779A (zh) 2019-03-11 2021-12-10 建新公司 切向病毒过滤
CA3135611A1 (en) * 2019-04-03 2020-10-08 Genzyme Corporation Continuous production of recombinant proteins
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
US20230181796A1 (en) * 2020-05-14 2023-06-15 North Carolina State University Fast automated approach for the derivation of acellular extracellular matrix scaffolds from tissues
JP2023544163A (ja) * 2020-10-02 2023-10-20 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 連続的なウイルス捕捉濾過
WO2025019797A2 (en) * 2023-07-19 2025-01-23 Hatchless Inc. System and method for low-cost sterilization of liquids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0422874A (ja) * 1990-05-16 1992-01-27 Matsushita Electric Ind Co Ltd 波形表示装置
GB2352652A (en) 1999-08-06 2001-02-07 Fsm Technologies Ltd Pre-treating hollow fibre membranes for micro-organism detection
US6485686B1 (en) * 1999-09-17 2002-11-26 The United States Of America As Represented By The Secretary Of The Army Method and apparatus for counting submicron sized particles
AU1811301A (en) 1999-12-02 2001-06-12 General Hospital Corporation, The Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
US6485688B1 (en) 2000-04-24 2002-11-26 General Electric Company On-line sparging sampling and monitoring systems and methods
US6630016B2 (en) * 2002-01-31 2003-10-07 Koslow Technologies Corp. Microporous filter media, filtration systems containing same, and methods of making and using
US6835311B2 (en) * 2002-01-31 2004-12-28 Koslow Technologies Corporation Microporous filter media, filtration systems containing same, and methods of making and using
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
JP4874806B2 (ja) 2003-12-01 2012-02-15 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 液体因子vii組成物のウイルス濾過
DE102005047301B4 (de) * 2005-09-30 2009-04-16 Sartorius Stedim Biotech Gmbh Verfahren zum Nachweis der Virenabreicherung für die Validierung von Filtern und Filtrationsprozessen
US20070084788A1 (en) * 2005-10-14 2007-04-19 Millipore Corporation Ultrafiltration membranes and methods of making and use of ultrafiltration membranes
US8309029B1 (en) * 2009-03-26 2012-11-13 The United States Of America As Represented By The Secretary Of The Army Virus and particulate separation from solution
US8945895B2 (en) * 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
MX2012002129A (es) * 2009-08-20 2012-06-08 Baxter Int Purificacion del factor de von willebrand (vwf) para remocion incrementada de virus envueltos sin lipido.
BR112014031842B1 (pt) * 2012-06-21 2020-09-15 Baxalta GmbH Método para remover um contaminante viral de uma preparação

Similar Documents

Publication Publication Date Title
JP2015529447A5 (cg-RX-API-DMAC7.html)
MY195362A (en) Virus Filtration of Cell Culture Media
EP4559926A3 (en) Virus filtration methods
RU2013119415A (ru) Способ получения поксвирусов и композиции поксвирусов
JP2019528740A5 (cg-RX-API-DMAC7.html)
WO2012074637A3 (en) Methods for removing plasma
CN102086234B (zh) 一种提高中分子量羟乙基淀粉质量的制备方法
IN2012DN04927A (cg-RX-API-DMAC7.html)
EP3371302B1 (en) Method for the separation of virus compositions including depletion and purification thereof
KR20050071582A (ko) 혈장 제제 또는 혈청 제제, 및 그의 제조 방법
ES2899389T3 (es) Procedimiento para tratar una solución contaminada con circovirus porcinos
CN102174482A (zh) 从有蓝藻爆发的水体中分离纯化噬藻体的方法
WO2011110073A1 (zh) 细胞培养混合物的分离纯化方法
WO2016201706A1 (zh) 一种植物分子纯化技术集成系统
WO2016189177A8 (es) Mejoras introducidas en la patente de invención p200931042 por: equipo para depuración de aire
CN107847541A (zh) 克隆并进一步纯化以制备重组静脉注射免疫球蛋白的方法
CN204522494U (zh) 一种液体制剂中活性炭快速过滤的装置
CN113825835A (zh) 使用渗滤方法有效去除杂质
CN103768589B (zh) 利用中空纤维膜去除人用乙型脑炎疫苗制品中残留dna的方法
CN202508949U (zh) 一种制备无菌海水的净化过滤装置
Van Reis Membrane Processes in the Biotechnology Industry
JPH07215891A (ja) 筋注用グロブリン製剤の製造方法
CN204824431U (zh) 一种膜过滤净化装置
MY188877A (en) Method to improve virus removal in protein purification
JP2013075838A (ja) 精製ヘモグロビンの製造方法